← Back to Clinical Trials
Recruiting NCT05301543

NCT05301543 Insomnia Behavioral Intervention Study

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05301543
Status Recruiting
Phase
Sponsor University of Pennsylvania
Condition Chronic Insomnia
Study Type INTERVENTIONAL
Enrollment 20 participants
Start Date 2022-01-10
Primary Completion 2027-04-08

Eligibility & Interventions

Sex All sexes
Min Age 55 Years
Max Age 85 Years
Study Type INTERVENTIONAL
Interventions
Experimental: Behavioral approach 1Comparator: Behavioral approach 2

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 20 participants in total. It began in 2022-01-10 with a primary completion date of 2027-04-08.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This randomized pilot study (n=20) explores the effects of a behavioral intervention, that includes sleep hygiene improvements, in long-term users of sleeping pills, aiming to alleviate or stabilize symptoms of insomnia, monitor and decrease sleeping pill usage. Adherence will be monitored by an optional smartphone application.

Eligibility Criteria

Inclusion Criteria: * Age of 55-85 * Use of sleeping pill medication for sleep at least 3 nights a week * Diagnosed with Chronic Insomnia by a physician * Speaks English above a 6th-grade level * Has access to a smartphone and/or smart tablet and can use it * Has regular access to internet Exclusion Criteria: * Presence of major depression or other severe psychopathology (e.g., bipolar disorder, psychosis, alcohol/substance abuse, etc.) * Presence of an acute or severe medical condition which, in the opinion of the research team, would interfere with the study participant's ability to participate in the research study, such as an acute heart attack, recent severe trauma, etc.

Contact & Investigator

Central Contact

Alex J Mathew

✉ alex.mathew@pennmedicine.upenn.edu

📞 215-596-9715

Frequently Asked Questions

Who can join the NCT05301543 clinical trial?

This trial is open to participants of all sexes, aged 55 Years or older, up to 85 Years, studying Chronic Insomnia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05301543 currently recruiting?

Yes, NCT05301543 is actively recruiting participants. Contact the research team at alex.mathew@pennmedicine.upenn.edu for enrollment information.

Where is the NCT05301543 trial being conducted?

This trial is being conducted at Philadelphia, United States.

Who is sponsoring the NCT05301543 clinical trial?

NCT05301543 is sponsored by University of Pennsylvania. The trial plans to enroll 20 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology